Lancet Infect Dis:下呼吸道感染的发病率、死亡率和病因知多少——来自195个国家的分析

2018-11-08 吴星 环球医学

下呼吸道感染是世界上死亡率和发病率的首要原因。2018年9月,发表在《Lancet Infect Dis》的一项全球疾病负担研究2016的系统分析,评估了195个国家下呼吸道感染的全球、地区和国家发病率、死亡率和病因。

下呼吸道感染是世界上死亡率和发病率的首要原因。2018年9月,发表在《Lancet Infect Dis》的一项全球疾病负担研究2016的系统分析,评估了195个国家下呼吸道感染的全球、地区和国家发病率、死亡率和病因。

背景:下呼吸道感染是世界上死亡率和发病率的首要原因。全球疾病负担、损伤和风险因素研究(GBD)2016提供了195个国家下呼吸道感染负担的更新分析。本研究评估了过去26年的病例、死亡、病因,展示了所有年龄中下呼吸道感染负担如何改变。

方法:研究人员对GBD2016的下呼吸道感染使用了3个独立的建模策略:贝叶斯分层集成建模平台(死因集成建模),该平台使用了人口登记、死因推断数据和监测系统数据,从而预测因下呼吸道感染造成的死亡;分隔Meta回归工具(DisMod-MR),该工具使用了科学文献、人口代表调查和医疗数据,从而预测发病率、患病率和死亡率;因肺炎链球菌、B型流感嗜血杆菌、流感、呼吸道合胞病毒造成的下呼吸道感染发作的人口归因分数的反事实估计模型。对于每个年龄、性别、年份和地点,研究人员计算了每个模型的评估值。研究人员使用DisMod-MR和时空高斯过程回归,对给定风险因素人群的暴露水平进行了建模,并评估了5岁以下儿童中,每个风险因素的靶向干预的有效性。研究人员使用GBD2016中下呼吸道感染相关的风险因素,对2000~2016年下呼吸道感染死亡的改变进行了分解分析。

结果:2016年,下呼吸道感染造成世界上652572例5岁以下儿童死亡(95%不确定区间(UI),586475~720612),1080958例70岁以上成人死亡(943749~1170638),2377697例所有年龄死亡(2145584~2512809)。肺炎链球菌为全球下呼吸道感染发病率和死亡率的首要原因,2016年,其造成的死亡比所有其他病因造成死亡的组合还要多(1189937例;95% UI,690445~1770660)。儿童营养不良仍然是5岁以下儿童下呼吸道感染死亡的首要风险因素,占到了2016年下呼吸道感染死亡的61.4%(95% UI,45.7~69.6)。在下呼吸道感染负担最高的国家中,每对4000名儿童实施改善营养不良、家庭空气污染、大气颗粒物污染和扩大抗生素使用的干预措施,可避免1例下呼吸道感染造成的5岁以下儿童死亡。

结论:结果表明,在降低下呼吸道感染负担上取得了实质性进展,但是该进展并不是在所有地区都相等。取得的进展主要由一些主要风险因素的降低造成,需要对老年人给予更多的努力。通过强调具有最高负担的地区和人口负担,以及具有最高影响的风险因素,资助者、政策制定者和项目实施者可更有效地减少世界上最易感人群的下呼吸道感染。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1829877, encodeId=711918298e7c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Sep 12 14:54:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012853, encodeId=ab782012853ec, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jan 31 07:54:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823506, encodeId=681f1823506e3, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 15 03:54:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282473, encodeId=f9f312824e373, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486535, encodeId=24ce14865355c, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=)]
    2019-09-12 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1829877, encodeId=711918298e7c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Sep 12 14:54:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012853, encodeId=ab782012853ec, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jan 31 07:54:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823506, encodeId=681f1823506e3, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 15 03:54:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282473, encodeId=f9f312824e373, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486535, encodeId=24ce14865355c, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1829877, encodeId=711918298e7c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Sep 12 14:54:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012853, encodeId=ab782012853ec, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jan 31 07:54:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823506, encodeId=681f1823506e3, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 15 03:54:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282473, encodeId=f9f312824e373, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486535, encodeId=24ce14865355c, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1829877, encodeId=711918298e7c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Sep 12 14:54:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012853, encodeId=ab782012853ec, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jan 31 07:54:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823506, encodeId=681f1823506e3, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 15 03:54:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282473, encodeId=f9f312824e373, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486535, encodeId=24ce14865355c, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=)]
    2018-11-10 zhmscau
  5. [GetPortalCommentsPageByObjectIdResponse(id=1829877, encodeId=711918298e7c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Sep 12 14:54:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012853, encodeId=ab782012853ec, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jan 31 07:54:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823506, encodeId=681f1823506e3, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 15 03:54:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282473, encodeId=f9f312824e373, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486535, encodeId=24ce14865355c, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Sat Nov 10 09:54:00 CST 2018, time=2018-11-10, status=1, ipAttribution=)]

相关资讯

盘点:流感近期重要研究一览

流行性感冒(以下简称流感)是由流感病毒引起的对人类健康危害较重的急性呼吸道传染病,病毒易变异,呈季节性流行特点,是全球关注的重要公共卫生问题。在世界范围内,每年有大约300-500万严重流感患者,超过100万患者需要住院接受护理,大约65万人因此去世。我国2017年流感疫情明显高发,局部地区出现暴发流行。天气逐渐转冷,流感又现抬头趋势,那么有关流感近期重要研究如何呢?让我们来一起了解一下:【1

BMJ:非复杂性下呼吸道感染为何**延迟抗菌药物使用?

急性非复杂性呼吸道感染是发达国家初级医疗中最常见的急性疾病,相当多的患者依然接受抗菌药物治疗。发表在《BMJ》的一项由英国和美国科学家进行的前瞻性咳嗽并发症队列(3C)研究,考察了非复杂性下呼吸道感染的抗菌药物处方策略和不良结局。

PLoS ONE:存在遗传易感背景的儿童生命早期患有下呼吸道感染日后哮喘的风险大大升高

发表于PLoS ONE的一项研究发现,2岁前患支气管炎且存在纤溶酶原激活物抑制物-1基因的常见变异的儿童日后发生哮喘的风险增加17倍。 此外,存在纤溶酶原激活物抑制剂-1(PAI-1)基因且生命早期患有下呼吸道感染需要医疗护理的儿童,无论轻重,其哮喘的发生风险增加12倍。 研究人员评估了3483名伴或不伴有哮喘的拉丁美洲儿童,年龄在8-21岁。 总的来说,只有存在PAI-1基

Blood:产生丁酸盐的肠道菌群可降低allo-HSCT后的患者发生呼吸道病毒感染的风险

中心点:allo-HSCT后,产生丁酸盐的细菌的丰富度与抗病毒性下呼吸道感染的保护作用相关。摘要:进行异体造血干细胞移植(allo-HCT)的患者常发生呼吸道病毒感染,还有可能进展成下呼吸道感染(LRTI)。肠道菌群有助于抵抗肺部病毒和细菌病原体入侵。但在allo-hct背景下,肠道菌群的组成及相关的微生物衍生代谢产物的变化是否会影响上呼吸道病毒感染后发生LRTI的风险尚未进行过研究。研究人员收集

Eur Respir J:免疫抑制对呼吸机相关性下呼吸道感染发病率、病原学和转归的影响!

由此可见,免疫功能低下者发生VA-LRTI的比例显著降低,但它与较高的死亡率相关。在免疫功能低下的VA-LRTI患者中经常出现多药耐药菌感染。